Salinomycin(SLM) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Salinomycin(SLM) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-36-1 | 1. BSA-Salinomycin(SLM) 2. Anti-Salinomycin(SLM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-36-2 | 1. OVA-Salinomycin(SLM) 2. Anti-Salinomycin(SLM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-36-3 | 1. BSA-Salinomycin(SLM) 2. Anti-Salinomycin(SLM) human monoclonal antibody | $2709.00 |
GMP-SMT-36-4 | 1. OVA-Salinomycin(SLM) 2. Anti-Salinomycin(SLM) human monoclonal antibody | $2709.00 |
GMP-SMT-36-Ag-1 | BSA-Salinomycin(SLM) | $756.00 |
GMP-SMT-36-Ag-2 | OVA-Salinomycin(SLM) | $756.00 |
GMP-SMT-36-Ab-1 | Anti-Salinomycin(SLM) mouse monoclonal antibody | $1953.00 |
GMP-SMT-36-Ab-2 | Anti-Salinomycin(SLM) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Salinomycin(SLM)
Cat No. | GMP-SMT-36-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Salinomycin(SLM) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Salinomycin(SLM) had been validated with our anti-Hapten antibody Anti-Salinomycin(SLM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Salinomycin(SLM)
Cat No. | GMP-SMT-36-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Salinomycin(SLM) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Salinomycin(SLM) had been validated with our anti-Hapten antibody Anti-Salinomycin(SLM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Salinomycin(SLM) mouse monoclonal antibody
Cat No. | GMP-SMT-36-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 4-5 |
Products description | The anti-Hapten antibody against hapten Salinomycin(SLM) had been validated with our hapten hapten-carrier conjugates BSA-Salinomycin(SLM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Salinomycin(SLM) human monoclonal antibody
Cat No. | GMP-SMT-36-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 4-5 |
Products description | The anti-Hapten antibody against hapten Salinomycin(SLM) had been validated with our hapten hapten-carrier conjugates BSA-Salinomycin(SLM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1.Salinomycin (SLM) holds a prominent position in the domain of veterinary medicine, serving as a polyether ionophore antibiotic with a critical role in combatting coccidiosis, a parasitic disease that heavily impacts the livestock industry. As part of the category of small molecules, SLM plays a pivotal role in veterinary practice, particularly in poultry, swine, and cattle management. This description will delve deeper into the multifaceted nature of Salinomycin and its applications in the context of veterinary drug residues and additives.
2.The Significance of Salinomycin (SLM):
Salinomycin is a polyether ionophore antibiotic, a class of compounds known for their ability to transport ions across biological membranes. Developed for veterinary use, Salinomycin exhibits unique properties that make it an effective tool in the management of coccidiosis, a protozoan parasitic disease that impacts various livestock species. The disease can lead to considerable economic losses due to reduced growth rates, impaired reproduction, and increased mortality among infected animals. Salinomycin's utility lies in its capacity to control coccidiosis and mitigate these detrimental effects, making it a vital component of veterinary disease management.
3.Role in Veterinary Drug Residues and Additives:
Salinomycin is primarily employed as a coccidiostat in veterinary practice. Coccidiostats are substances that control coccidiosis, a disease caused by the protozoan parasites from the genus Eimeria. This disease commonly affects poultry, swine, and cattle, and it poses a significant challenge to the livestock industry. The key role of Salinomycin is to effectively suppress the proliferation of these parasitic organisms.
In addition to its therapeutic role in controlling coccidiosis, Salinomycin is used as a feed additive in some cases. It promotes animal health and growth, particularly in poultry and swine. As an ionophore antibiotic, it can improve nutrient utilization, leading to enhanced feed efficiency and growth performance in these animals. This dual role of Salinomycin as both a therapeutic agent and a growth promoter underscores its importance in veterinary medicine.
4.Why Measure Salinomycin (SLM)?
The measurement of Salinomycin levels is a critical aspect of ensuring the safety, efficacy, and compliance of veterinary products and practices. There are several key reasons why the accurate measurement of Salinomycin is imperative:
a. Regulatory Compliance: Regulatory agencies in many countries have established maximum residue limits (MRLs) for Salinomycin in animal-derived food products. These limits are in place to ensure that the residues of Salinomycin in animal products do not exceed safe levels for human consumption. Accurate measurement is essential to demonstrate compliance with these regulatory standards and avoid legal issues.
b. Food Safety: Ensuring the safety of food products derived from animals is of paramount importance. Excessive Salinomycin residues in these products can pose health risks to consumers. Monitoring and measuring Salinomycin levels in animal tissues and products are vital steps in safeguarding public health.
c. Quality Control: In veterinary medicine, precise measurement of Salinomycin is crucial to ascertain that the correct therapeutic dosage is administered to animals. This is essential to maintain the quality and efficacy of veterinary products and treatments. Inaccurate dosing can lead to treatment failure or, in some cases, adverse effects on animals.
d. Antibiotic Resistance Mitigation: Overuse or misuse of antibiotics, including Salinomycin, can contribute to the development of antibiotic-resistant bacteria. Accurate measurement and responsible use of Salinomycin are crucial in preventing antibiotic resistance, a global health concern.
e. Animal Health and Welfare: Accurate measurement of Salinomycin levels is vital to ensure that animals receive the appropriate therapeutic dosage. This promotes animal health and welfare by effectively controlling coccidiosis and improving overall well-being. Under-dosing can lead to inadequate disease control, while over-dosing can result in potential harm to animals.
5.The Role of Biopharmaceutical Products:
Biopharmaceutical companies play a significant role in facilitating the measurement of Salinomycin levels. They provide a range of tools and reagents, including anti-small molecule antibodies and competitive antigens, to support accurate and precise quantification of Salinomycin. These products are instrumental in enabling laboratories and veterinary professionals to conduct assays and tests to determine the concentration of Salinomycin in various samples.
Anti-small molecule antibodies are essential in immunoassays designed to detect and quantify Salinomycin. They specifically bind to Salinomycin molecules, forming the basis for highly sensitive and specific assays. Competitive antigens, such as carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated compounds, are used in various immunoassays to compete with Salinomycin for binding to antibodies, allowing precise quantification of the analyte.
In conclusion, the measurement of Salinomycin (SLM) in the context of veterinary drug residues and additives is a critical aspect of ensuring regulatory compliance, food safety, quality control, antibiotic resistance prevention, and animal health. Biopharmaceutical companies offer valuable products that empower the scientific community to accurately assess Salinomycin levels, contributing to the well-being of animals and the safety of food products derived from them. The multifaceted role of Salinomycin in veterinary medicine underscores its significance in the livestock industry, and the accurate measurement of this small molecule is paramount for the overall health and welfare of animals and consumers.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.